Zenotech Laboratories Limited (BOM:532039)
46.25
+0.44 (0.96%)
At close: Aug 21, 2026
Zenotech Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,823 | 2,093 | 3,169 | 3,608 | 2,872 | 3,073 | |
Market Cap Growth | -17.41% | -33.96% | -12.16% | 25.61% | -6.53% | 43.86% |
Enterprise Value | 2,518 | 1,775 | 2,949 | 3,454 | 2,788 | 3,161 |
Last Close Price | 46.25 | 34.29 | 51.92 | 59.11 | 47.06 | 50.35 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 56.45 | 43.47 | 24.79 | 13.86 |
PS Ratio | 6.97 | 5.29 | 8.10 | 9.80 | 7.36 | 9.33 |
PB Ratio | 2.97 | 2.20 | 3.30 | 3.98 | 3.49 | 4.35 |
P/TBV Ratio | 2.97 | 2.20 | 3.30 | 3.98 | 3.49 | 4.35 |
P/FCF Ratio | 149.94 | 111.17 | 56.33 | 47.54 | 19.90 | 19.54 |
P/OCF Ratio | 27.66 | 20.51 | 33.40 | 30.51 | 13.90 | 17.39 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 6.22 | 4.49 | 7.54 | 9.39 | 7.15 | 9.60 |
EV/EBITDA Ratio | 33.57 | 19.32 | 20.60 | 19.96 | 13.05 | 17.65 |
EV/EBIT Ratio | - | 85.56 | 40.07 | 33.79 | 19.65 | 28.89 |
EV/FCF Ratio | 133.78 | 94.31 | 52.43 | 45.52 | 19.32 | 20.10 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | - | - | - | - | - | 0.09 |
Debt / EBITDA Ratio | - | - | - | - | - | 0.33 |
Debt / FCF Ratio | - | - | - | - | - | 0.38 |
Net Debt / Equity Ratio | -0.32 | -0.32 | -0.28 | -0.22 | -0.13 | 0.05 |
Net Debt / EBITDA Ratio | -4.05 | -3.31 | -1.86 | -1.14 | -0.52 | 0.20 |
Net Debt / FCF Ratio | - | -16.16 | -4.75 | -2.59 | -0.77 | 0.23 |
Asset Turnover | - | 0.36 | 0.36 | 0.36 | 0.40 | 0.37 |
Inventory Turnover | - | - | 9.10 | 6.99 | 37.00 | 27.60 |
Quick Ratio | - | 3.25 | 2.80 | 1.81 | 0.91 | 0.42 |
Current Ratio | - | 3.40 | 2.86 | 1.94 | 0.98 | 0.47 |
Return on Equity (ROE) | - | -1.12% | 6.01% | 9.60% | 15.15% | 37.26% |
Return on Assets (ROA) | - | 1.17% | 4.23% | 6.17% | 9.10% | 7.60% |
Return on Invested Capital (ROIC) | -0.59% | -0.79% | 5.51% | 10.73% | 15.60% | 15.54% |
Return on Capital Employed (ROCE) | - | 2.10% | 7.50% | 11.00% | 16.80% | 13.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -0.89% | -0.51% | 1.77% | 2.30% | 4.03% | 7.22% |
FCF Yield | 0.67% | 0.90% | 1.77% | 2.10% | 5.03% | 5.12% |
Buyback Yield / Dilution | 1.23% | 2.41% | - | - | - | - |